|Status||Country of risk||Maturity (option)|
This field shows outstanding face value amount for outstanding bonds
|Issue ratings (M/S&P/F)|
|outstanding||USA||**/**/**** (**/**/****)||4,400,000 USD||***/***/***|
|Borrower||Bristol Myers Squibb|
|Bond type||Coupon bonds|
|Placement method||Open subscription|
Bristol-Myers Squibb expects to use the net proceeds from the Offering to fund a portion of the aggregate cash portion of the merger consideration to be paid to Celgene shareholders in connection with the Merger and to pay related fees and expenses, with any remaining proceeds being used for general corporate purposes.
|Par amount, integral multiple||1,000 USD|
|Nominal of international bonds||1,000 USD|
|Minimum settlement amount||2,000 USD|
|Outstanding principal amount||2,000 USD|
|Amount Outstanding||4,400,000 USD|
|Outstanding face value amount||4,400,000 USD|
|Exchanged into||Bristol Myers Squibb, 4.125% 15jun2039, USD|
|Other tranches||Bristol Myers Squibb, 3.2% 15jun2026, USD, Bristol Myers Squibb, 2.9% 26jul2024, USD, Bristol Myers Squibb, 4.25% 26oct2049, USD, Bristol Myers Squibb, 3.4% 26jul2029, USD, Bristol Myers Squibb, FRN 16nov2020, USD, Bristol Myers Squibb, 2.55% 14may2021, USD, Bristol Myers Squibb, FRN 16may2022, USD, Bristol Myers Squibb, 2.6% 16may2022, USD|
|Current coupon rate||4.125%|
|Day count fraction||***|
|Coupon frequency||2 time(s) per year|
|Interest accrual date||**/**/****|
|Trading floor||Date and time||Bid/ ask price (Yield)|
Indicative price (Yield) i
Indicative price is used to calculate the effective yield, duration, modified duration and is calculated according to the following priority of prices: weighted average price (Average), market price (Market), closing price (Close), admitted price (Admitted), middle price (Mid), last price (Last). Indicative yield is calculated according to the following priority of yields: yield to maturity (effective), yield to put/call (effective), current yield.
T-spread, bp i
T-spread is calculated as the difference between the issue yield and the yield on government securities of the USA, Great Britain and Germany in the corresponding issue currency and with comparable modified duration (the calculations are based on the effective yields only). The value is computed only for issues in USD, EUR, GBP.
Indicative bond and international bond quotes by Cbonds are calculated based on the methodology described here http://ru.cbonds.com/organizations/docdownload/8715.
The end result of the methodology is a single end-of-day Cbonds quote, which is based on bid and ask data of various trading floors and contributors working with this asset.
Quotes are published both anonymously and publicly in the section Bond Quotes by Market Participants: http://cbonds.com/quotes/market/. These quotes are indicative only. Organizations posting the quotes have no obligations to conduct transactions at these prices. To learn the actual current prices, you need to contact the respective organization. Trading floor quotes are available at http://cbonds.com/quotes/.
|09/25/2020||*** / *** (*** / ***)||*** (***)||***||***||Archive|
|Trading floor||Date and time||Bid/ ask price (Yield)||G-spread|
|09/28/2020||*** / *** (*** / ***)||*** (***)||***||***||Archive|
|Supranational bond issues|
|ISIN / ISIN RegS||USU11009BC71|
|CUSIP / CUSIP RegS||U11009BC7|
|CFI / CFI RegS||DBFNGR|
|FIGI / FIGI RegS||BBG00P341DY5|
|WKN / WKN RegS||A2R179|
|Ticker||BMY 4.125 06/15/39 REGS|
|Issuer rating on issue date (M/S&P/F)||***/***/***|
|Initial issue price (yield)||**.***% (*.**%)|
|Bookrunner:||Barclays, Credit Suisse, Deutsche Bank, HSBC, Morgan Stanley, Mitsubishi UFJ Financial Group, Wells Fargo|
|Depository:||Clearstream Banking S.A., Euroclear Bank|